EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?

Serena Maria Boccia, Carolina Maria Sassu iD, Raffaella Ergasti, Laura Vertechy, Adriana Ionelia Apostol iD, Eleonora Palluzzi, Anna Fagotti, Giovanni Scambia, Claudia Marchetti

Drug Design, Development and Therapy · 2024-06 · Volume 18 · 2021-2032

DOI: 10.2147/dddt.s451223 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-06. Verfasst von Serena Maria Boccia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, …. Hauptthemen laut MEDLINE: Trabectedin, Ovarian Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrabectedinOvarian NeoplasmsHumansFemaleAntineoplastic Agents, AlkylatingTetrahydroisoquinolinesDioxolesDoxorubicinPolyethylene GlycolsAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

ovarian cancerplatinum eligibilitytrabectedin

Substanzen

TrabectedinAntineoplastic Agents, AlkylatingTetrahydroisoquinolinesDioxolesDoxorubicinPolyethylene Glycolsliposomal doxorubicin

Autor:innen und Institutionen

  • Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, 00136, Italy.
  • Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, 00136, Italy.

ORCID-Profile: Carolina Maria Sassu, Adriana Ionelia Apostol

Zitieren

APA

Boccia, S. M., Sassu, C. M., Ergasti, R., Vertechy, L., Apostol, A. I., Palluzzi, E., Fagotti, A., Scambia, G., & Marchetti, C. (2024). Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?. Drug Design, Development and Therapy, Volume 18, 2021-2032. https://doi.org/10.2147/dddt.s451223

Vancouver

Boccia SM, Sassu CM, Ergasti R, Vertechy L, Apostol AI, Palluzzi E, et al. Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?. Drug Design, Development and Therapy. 2024;Volume 18:2021-2032. doi:10.2147/dddt.s451223

BibTeX
@article{Boccia2024,
  author = {Boccia, Serena Maria and Sassu, Carolina Maria and Ergasti, Raffaella and Vertechy, Laura and Apostol, Adriana Ionelia and Palluzzi, Eleonora and Fagotti, Anna and Scambia, Giovanni and Marchetti, Claudia},
  title = {Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  volume = {Volume 18},
  pages = {2021--2032},
  doi = {10.2147/dddt.s451223}
}
Kostenlos starten →